Immunex Enbrel

Supplemental BLA submitted July 15 for slowing structural damage and improving the signs and symptoms of early, active rheumatoid arthritis. FDA approved etanercept in November 1998 to treat moderately to severely active RA in patients with no successful drug alternatives and extended the indication to children in May